These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36936866)
1. Spesolimab use in treatment of pyoderma gangrenosum. Guénin SH; Khattri S; Lebwohl MG JAAD Case Rep; 2023 Apr; 34():18-22. PubMed ID: 36936866 [No Abstract] [Full Text] [Related]
2. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis. Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618 [TBL] [Abstract][Full Text] [Related]
3. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis. Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325 [TBL] [Abstract][Full Text] [Related]
4. Development of pemphigus vegetans and exacerbation of pemphigus foliaceus after secukinumab loading in a patient with complicated generalized pustular psoriasis and pyoderma gangrenosum. Minai L; Takeichi T; Ogawa Y; Honobe-Tabuchi A; Okamoto T; Mitsui H; Shimada S; Akiyama M; Kawamura T J Dermatol; 2023 Feb; 50(2):245-249. PubMed ID: 36052669 [TBL] [Abstract][Full Text] [Related]
5. Spesolimab: A Review of the First IL-36 Blocker Approved for Generalized Pustular Psoriasis. Pathak GN; Wang E; Dhillon J; Parikh PN; Esseghir R; Rao BK; Feldman SR Ann Pharmacother; 2024 May; ():10600280241252688. PubMed ID: 38755971 [TBL] [Abstract][Full Text] [Related]
6. Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis. Shao S; Wang G Dermatol Ther (Heidelb); 2022 Dec; 12(12):2627-2635. PubMed ID: 36208408 [TBL] [Abstract][Full Text] [Related]
10. Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study. Navarini AA; Prinz JC; Morita A; Tsai TF; Viguier MA; Li L; Thoma C; Sivalingam M; Lebwohl MG J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):730-736. PubMed ID: 36527385 [TBL] [Abstract][Full Text] [Related]
11. Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report. Nazir A; Zafar A Cureus; 2022 May; 14(5):e25177. PubMed ID: 35746991 [TBL] [Abstract][Full Text] [Related]
12. Spesolimab: First Approval. Blair HA Drugs; 2022 Nov; 82(17):1681-1686. PubMed ID: 36418672 [TBL] [Abstract][Full Text] [Related]
13. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options. Menter A; Van Voorhees AS; Hsu S Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330 [TBL] [Abstract][Full Text] [Related]
14. Neutrophilic dermatoses: a review of current treatment options. Cohen PR Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous occurrence of Pyoderma Gangrenosum and Palmoplantar Pustular Psoriasis: Is it an association or coincidental findings? Pukar C; Sudha A; Punam P Clin Case Rep; 2021 Jan; 9(1):410-415. PubMed ID: 33489191 [TBL] [Abstract][Full Text] [Related]
16. Modified dose of guselkumab for treatment of pyoderma gangrenosum. Reese AM; Erickson K; Reed KB; Ortega-Loayza AG JAAD Case Rep; 2022 Mar; 21():38-42. PubMed ID: 35146098 [No Abstract] [Full Text] [Related]
17. Pure Bullous Pyoderma Gangrenosum, a Challenging Clinico-Pathological Diagnosis: Critical Literature Review with Emphasis on Diagnostic Criteria. García-Abellás P; Fernández-Guarino M; Díaz-Guimaraens B; Soto-Castillo JJ; Torres-Jiménez J; Carrillo-Gijón R Indian J Dermatol; 2022; 67(4):409-414. PubMed ID: 36578743 [TBL] [Abstract][Full Text] [Related]
18. Pyoderma Gangrenosum: An Ulcer With Unorthodox Treatment. Baruah TD; Ray R; R M Cureus; 2021 Nov; 13(11):e19324. PubMed ID: 34900493 [TBL] [Abstract][Full Text] [Related]
19. [Pathergic postsurgical-induced Pyoderma gangrenosum]. Wirtzfeld N; Paquet P; Lemineur T; Lutgen M; Bouaziz JD; Denoel C Rev Med Liege; 2017 May; 72(5):227-232. PubMed ID: 28520320 [TBL] [Abstract][Full Text] [Related]
20. Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report. Vallerand IA; Hardin J SAGE Open Med Case Rep; 2019; 7():2050313X19845206. PubMed ID: 31080598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]